Onxeo SA
XBER:C4X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Onxeo SA
XBER:C4X
|
FR |
|
Immobiliare Grande Distribuzione SIIQ SpA
MIL:IGD
|
IT |
|
Mount Ridley Mines Ltd
OTC:MRDMF
|
AU |
|
E
|
Everest Securities JSC
VN:EVS
|
VN |
|
TS Tech Co Ltd
OTC:TTCAF
|
JP |
|
Z
|
Zoomd Technologies Ltd
F:3ZD
|
CA |
|
P
|
Purit Co Ltd
KOSDAQ:445180
|
KR |
|
C
|
Cantor Equity Partners VI Inc
NASDAQ:CEPS
|
US |
|
S
|
Sojitz Corp
SWB:XEB
|
JP |
|
International Frontier Resources Corp
OTC:IFRTF
|
CA |
|
G
|
Grounds Real Estate Development AG
F:AMMN
|
DE |
|
Smartworks Coworking Spaces Ltd
NSE:SMARTWORKS
|
IN |
|
A
|
Amogreentech Co Ltd
KOSDAQ:125210
|
KR |
|
T
|
Tai Industries Ltd
BSE:519483
|
IN |
|
Supply@Me Capital PLC
F:IE6B
|
UK |
|
Dof ASA
F:4D6
|
NO |
|
MineralRite Corp
OTC:RITE
|
US |
|
B
|
Bathurst Resources Ltd
F:B0R
|
NZ |
Bankruptcy Probability
Onxeo SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Onxeo SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
O
|
Onxeo SA
PAR:ALONX
|
30.2m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
232.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Onxeo SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Onxeo SA has total debt of 8.8m EUR. This includes both short-term (0 EUR) and long-term (8.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
